Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kessler Hails Leadership, Torti Praises Staff For Brighter Future At FDA

This article was originally published in The Tan Sheet

Executive Summary

Former Commissioner David Kessler sees the appointment of tandem leadership at FDA as a way to re-establish stability and longevity for the agency's senior management

You may also be interested in...



Sharfstein Is Acting FDA Commissioner As Hamburg Awaits Confirmation

Josh Sharfstein will begin his FDA career March 30, serving as acting commissioner while awaiting the confirmation of President Obama's nominee for the spot, Margaret Hamburg

Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA

FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS102803

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel